drugset / Trial / NCT01698684

Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction

NCT01698684

Phase 4 Completed 440 enrolled VIVUS LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this study are to examine the therapeutic effects of two doses of avanafil after dosing in men with erectile dysfunction

Timeline

Start
2012-09
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Avanafil Small molecule 100 mg
Subject Avanafil Small molecule 200 mg

Indications